ArticleChina CDC weekly2025

The Clinical Advantages of Anti-Rabies Monoclonal Antibodies in Post-Exposure Prophylaxis - Worldwide, 2016-2025.

Qingjun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.